跳至主要内容
临床试验/NCT02801253
NCT02801253招募中不适用

Prospective Cohort of Patients With Prosthetic Joint Infection

Groupe Hospitalier Diaconesses Croix Saint-Simon1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2015年9月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
800
试验地点
1
主要终点
Number of patients with hip and knee prosthetic joint reinfection (relapse and new infection) and multi-variable analysis of reinfection risk factors

研究概览

简要总结

Management of prosthetic joint infections (PJI) is a challenging task. These infections include different clinical and microbiological settings calling upon various treatment strategies according to infection type (acute or chronic), bone quality, the involved micro-organism and the patient's general condition and willing.

Treatment of PJI combines surgery and prolonged antibiotic therapy. In some patients with a high operative risk prolonged suppressive antibiotic therapy can be used.

Lack of large prospective studies motivated the conception of this cohort with a long term follow up, regardless to PJI management procedures.

详细描述

Large prospective cohort study in a French referral center for bone and joint infections.

Population

  • all patients who consented to participate in the study with PJI treated with:
  • debridement-synovectomy for acute infection
  • with one-stage, two-stage exchange arthroplasty for chronic infection
  • other procedures (complete removal of the prosthesis) and antibiotic therapy
  • patients (non-operated or operated) receiving prolonged suppressive antibiotic therapy

Outcome:

  • Follow-up at least 2 years
  • Events monitored: reinfection including relapse and new infection, joint revision for mechanical failure, PJI related or non-related death Study duration: 10 years. Recruitment period: 4 years. Maximal duration of data collection: 6 years. Investigator center: monocenter study. Mean patient inclusion per year: 100 patients per year.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged over 18 years old with hip, knee and or shoulder joint prosthesis who consented to participate in the study with:
  • According to musculoskeletal infection society definition: PJI is present when one of the major criteria exists or four out of six minor criteria.
  • Major Criteria:
  • Two positive periprosthetic cultures with phenotypically identical organisms, OR
  • A sinus tract communicating with the joint, OR
  • Minor Criteria:
  • Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR)
  • Elevated synovial fluid white blood cell (WBC)
  • Elevated synovial fluid polymorphonuclear neutrophil percentage (PMN%)
  • The presence of pus in the joint without known cause
  • Positive histological analysis of periprosthetic tissue
  • A single positive culture
  • Or a PJI which meets the following three criteria:
  • Medical story suggesting prosthetic joint infection.
  • The presence of pain either with or without swelling for more than 3 months unrelated to a mechanical cause.
  • Germ identification in a single sample of fluid aspiration or tissue culture.
  • Or microbial growth in prosthesis sonication fluid culture greater than 50CFU/ml.

排除标准

  • Patient who does not meet eligibility criteria.
  • Patient lawfully deprived of his liberty.
  • Patient not insured under social security scheme.

结局指标

主要结局

Number of patients with hip and knee prosthetic joint reinfection (relapse and new infection) and multi-variable analysis of reinfection risk factors

时间窗: 2 years

次要结局

  • Assessment of treatment failure rate in patients with hip and knee PJI 2 years after prolonged suppressive antibiotic therapy in non-operated patients.(2 years)
  • Assessment of reinfection rate of shoulder PJI two years after prosthesis revision with one or two stage exchange arthroplasty.(2 years)
  • Assessment of joint function at one, two, four and 6 years after prosthesis revision with one or two stage exchange arthroplasty.(1, 2, 4, 6 years)
  • Assessment of mechanical failure rate six years after prosthesis revision with one or two stage exchange arthroplasty(6 years)

研究者

发起方
Groupe Hospitalier Diaconesses Croix Saint-Simon
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Valerie ZELLER

infectious diseases specialist

Groupe Hospitalier Diaconesses Croix Saint-Simon

研究点 (1)

Loading locations...

相似试验